nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—colon cancer	0.806	1	CbGaD
Acebutolol—Amnesia—Capecitabine—colon cancer	0.000878	0.00455	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Capecitabine—colon cancer	0.000874	0.00453	CcSEcCtD
Acebutolol—Menopausal symptoms—Capecitabine—colon cancer	0.000874	0.00453	CcSEcCtD
Acebutolol—Hypoaesthesia—Vincristine—colon cancer	0.000871	0.00452	CcSEcCtD
Acebutolol—Hallucination—Vincristine—colon cancer	0.000871	0.00452	CcSEcCtD
Acebutolol—Bradycardia—Irinotecan—colon cancer	0.000868	0.0045	CcSEcCtD
Acebutolol—Connective tissue disorder—Vincristine—colon cancer	0.00086	0.00446	CcSEcCtD
Acebutolol—Rhinitis—Irinotecan—colon cancer	0.000855	0.00443	CcSEcCtD
Acebutolol—Agranulocytosis—Fluorouracil—colon cancer	0.000849	0.0044	CcSEcCtD
Acebutolol—Cardiac failure—Capecitabine—colon cancer	0.000845	0.00438	CcSEcCtD
Acebutolol—Lethargy—Capecitabine—colon cancer	0.000842	0.00437	CcSEcCtD
Acebutolol—Connective tissue disorder—Irinotecan—colon cancer	0.000838	0.00435	CcSEcCtD
Acebutolol—Pain in extremity—Capecitabine—colon cancer	0.000825	0.00428	CcSEcCtD
Acebutolol—Visual impairment—Irinotecan—colon cancer	0.000821	0.00426	CcSEcCtD
Acebutolol—Rhinitis—Fluorouracil—colon cancer	0.000818	0.00425	CcSEcCtD
Acebutolol—Hypoaesthesia—Fluorouracil—colon cancer	0.000812	0.00421	CcSEcCtD
Acebutolol—Pharyngitis—Fluorouracil—colon cancer	0.00081	0.0042	CcSEcCtD
Acebutolol—Angiopathy—Vincristine—colon cancer	0.000794	0.00412	CcSEcCtD
Acebutolol—Flushing—Irinotecan—colon cancer	0.000791	0.0041	CcSEcCtD
Acebutolol—Mediastinal disorder—Vincristine—colon cancer	0.000789	0.00409	CcSEcCtD
Acebutolol—Mood swings—Capecitabine—colon cancer	0.000781	0.00405	CcSEcCtD
Acebutolol—Alopecia—Vincristine—colon cancer	0.000773	0.00401	CcSEcCtD
Acebutolol—Angiopathy—Irinotecan—colon cancer	0.000773	0.00401	CcSEcCtD
Acebutolol—Mediastinal disorder—Irinotecan—colon cancer	0.000768	0.00399	CcSEcCtD
Acebutolol—Chills—Irinotecan—colon cancer	0.000765	0.00397	CcSEcCtD
Acebutolol—Alopecia—Irinotecan—colon cancer	0.000753	0.00391	CcSEcCtD
Acebutolol—Orthostatic hypotension—Capecitabine—colon cancer	0.000753	0.00391	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000743	0.00385	CcSEcCtD
Acebutolol—Back pain—Vincristine—colon cancer	0.000737	0.00382	CcSEcCtD
Acebutolol—Flatulence—Irinotecan—colon cancer	0.000731	0.00379	CcSEcCtD
Acebutolol—Alopecia—Fluorouracil—colon cancer	0.000721	0.00374	CcSEcCtD
Acebutolol—Back pain—Irinotecan—colon cancer	0.000718	0.00372	CcSEcCtD
Acebutolol—Bronchospasm—Capecitabine—colon cancer	0.000701	0.00364	CcSEcCtD
Acebutolol—Ill-defined disorder—Irinotecan—colon cancer	0.000688	0.00357	CcSEcCtD
Acebutolol—Vertigo—Vincristine—colon cancer	0.000685	0.00355	CcSEcCtD
Acebutolol—Vision blurred—Fluorouracil—colon cancer	0.00067	0.00347	CcSEcCtD
Acebutolol—Malaise—Irinotecan—colon cancer	0.000669	0.00347	CcSEcCtD
Acebutolol—Vertigo—Irinotecan—colon cancer	0.000667	0.00346	CcSEcCtD
Acebutolol—Dysuria—Capecitabine—colon cancer	0.000666	0.00346	CcSEcCtD
Acebutolol—Syncope—Irinotecan—colon cancer	0.000665	0.00345	CcSEcCtD
Acebutolol—Atenolol—ABCB1—colon cancer	0.000657	0.46	CrCbGaD
Acebutolol—Loss of consciousness—Irinotecan—colon cancer	0.000652	0.00338	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Methotrexate—colon cancer	0.000651	0.00338	CcSEcCtD
Acebutolol—Myalgia—Vincristine—colon cancer	0.000649	0.00337	CcSEcCtD
Acebutolol—Weight increased—Capecitabine—colon cancer	0.000649	0.00337	CcSEcCtD
Acebutolol—Visual disturbance—Methotrexate—colon cancer	0.000648	0.00336	CcSEcCtD
Acebutolol—Cough—Irinotecan—colon cancer	0.000647	0.00336	CcSEcCtD
Acebutolol—Pneumonia—Capecitabine—colon cancer	0.000639	0.00332	CcSEcCtD
Acebutolol—Depression—Capecitabine—colon cancer	0.000634	0.00329	CcSEcCtD
Acebutolol—Lethargy—Methotrexate—colon cancer	0.000626	0.00325	CcSEcCtD
Acebutolol—Discomfort—Irinotecan—colon cancer	0.000624	0.00324	CcSEcCtD
Acebutolol—Oedema—Vincristine—colon cancer	0.000622	0.00323	CcSEcCtD
Acebutolol—Conjunctivitis—Capecitabine—colon cancer	0.000618	0.0032	CcSEcCtD
Acebutolol—Confusional state—Irinotecan—colon cancer	0.000611	0.00317	CcSEcCtD
Acebutolol—Nervous system disorder—Vincristine—colon cancer	0.00061	0.00316	CcSEcCtD
Acebutolol—Oedema—Irinotecan—colon cancer	0.000606	0.00314	CcSEcCtD
Acebutolol—Myalgia—Fluorouracil—colon cancer	0.000605	0.00314	CcSEcCtD
Acebutolol—Chest pain—Fluorouracil—colon cancer	0.000605	0.00314	CcSEcCtD
Acebutolol—Hyperhidrosis—Vincristine—colon cancer	0.000601	0.00312	CcSEcCtD
Acebutolol—Discomfort—Fluorouracil—colon cancer	0.000598	0.0031	CcSEcCtD
Acebutolol—Shock—Irinotecan—colon cancer	0.000596	0.00309	CcSEcCtD
Acebutolol—Nervous system disorder—Irinotecan—colon cancer	0.000594	0.00308	CcSEcCtD
Acebutolol—Agranulocytosis—Capecitabine—colon cancer	0.000593	0.00308	CcSEcCtD
Acebutolol—Anorexia—Vincristine—colon cancer	0.000593	0.00308	CcSEcCtD
Acebutolol—Hyperhidrosis—Irinotecan—colon cancer	0.000585	0.00304	CcSEcCtD
Acebutolol—Confusional state—Fluorouracil—colon cancer	0.000585	0.00303	CcSEcCtD
Acebutolol—Mood swings—Methotrexate—colon cancer	0.000582	0.00302	CcSEcCtD
Acebutolol—Hypotension—Vincristine—colon cancer	0.000581	0.00301	CcSEcCtD
Acebutolol—Bradycardia—Capecitabine—colon cancer	0.000581	0.00301	CcSEcCtD
Acebutolol—Oedema—Fluorouracil—colon cancer	0.00058	0.00301	CcSEcCtD
Acebutolol—Anorexia—Irinotecan—colon cancer	0.000577	0.003	CcSEcCtD
Acebutolol—Rhinitis—Capecitabine—colon cancer	0.000572	0.00297	CcSEcCtD
Acebutolol—Nervous system disorder—Fluorouracil—colon cancer	0.000569	0.00295	CcSEcCtD
Acebutolol—Hypoaesthesia—Capecitabine—colon cancer	0.000568	0.00295	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Vincristine—colon cancer	0.000567	0.00294	CcSEcCtD
Acebutolol—Pharyngitis—Capecitabine—colon cancer	0.000566	0.00294	CcSEcCtD
Acebutolol—Hypotension—Irinotecan—colon cancer	0.000566	0.00294	CcSEcCtD
Acebutolol—Insomnia—Vincristine—colon cancer	0.000562	0.00292	CcSEcCtD
Acebutolol—Connective tissue disorder—Capecitabine—colon cancer	0.000561	0.00291	CcSEcCtD
Acebutolol—Paraesthesia—Vincristine—colon cancer	0.000558	0.0029	CcSEcCtD
Acebutolol—Anorexia—Fluorouracil—colon cancer	0.000553	0.00287	CcSEcCtD
Acebutolol—Visual impairment—Capecitabine—colon cancer	0.00055	0.00285	CcSEcCtD
Acebutolol—Insomnia—Irinotecan—colon cancer	0.000548	0.00284	CcSEcCtD
Acebutolol—Paraesthesia—Irinotecan—colon cancer	0.000544	0.00282	CcSEcCtD
Acebutolol—Hypotension—Fluorouracil—colon cancer	0.000542	0.00281	CcSEcCtD
Acebutolol—Decreased appetite—Vincristine—colon cancer	0.000541	0.0028	CcSEcCtD
Acebutolol—Dyspnoea—Irinotecan—colon cancer	0.00054	0.0028	CcSEcCtD
Acebutolol—Somnolence—Irinotecan—colon cancer	0.000538	0.00279	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Vincristine—colon cancer	0.000537	0.00279	CcSEcCtD
Acebutolol—Fatigue—Vincristine—colon cancer	0.000536	0.00278	CcSEcCtD
Acebutolol—Dyspepsia—Irinotecan—colon cancer	0.000533	0.00277	CcSEcCtD
Acebutolol—Tinnitus—Capecitabine—colon cancer	0.000532	0.00276	CcSEcCtD
Acebutolol—Constipation—Vincristine—colon cancer	0.000532	0.00276	CcSEcCtD
Acebutolol—Pain—Vincristine—colon cancer	0.000532	0.00276	CcSEcCtD
Acebutolol—Flushing—Capecitabine—colon cancer	0.000529	0.00275	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000528	0.00274	CcSEcCtD
Acebutolol—Decreased appetite—Irinotecan—colon cancer	0.000526	0.00273	CcSEcCtD
Acebutolol—Insomnia—Fluorouracil—colon cancer	0.000525	0.00272	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Irinotecan—colon cancer	0.000523	0.00271	CcSEcCtD
Acebutolol—Fatigue—Irinotecan—colon cancer	0.000522	0.00271	CcSEcCtD
Acebutolol—Paraesthesia—Fluorouracil—colon cancer	0.000521	0.0027	CcSEcCtD
Acebutolol—Constipation—Irinotecan—colon cancer	0.000518	0.00269	CcSEcCtD
Acebutolol—Pain—Irinotecan—colon cancer	0.000518	0.00269	CcSEcCtD
Acebutolol—Angiopathy—Capecitabine—colon cancer	0.000518	0.00269	CcSEcCtD
Acebutolol—Dyspnoea—Fluorouracil—colon cancer	0.000517	0.00268	CcSEcCtD
Acebutolol—Somnolence—Fluorouracil—colon cancer	0.000516	0.00268	CcSEcCtD
Acebutolol—Mediastinal disorder—Capecitabine—colon cancer	0.000514	0.00267	CcSEcCtD
Acebutolol—Chills—Capecitabine—colon cancer	0.000512	0.00266	CcSEcCtD
Acebutolol—Metoprolol—ABCB1—colon cancer	0.000512	0.359	CrCbGaD
Acebutolol—Dyspepsia—Fluorouracil—colon cancer	0.000511	0.00265	CcSEcCtD
Acebutolol—Gastrointestinal pain—Vincristine—colon cancer	0.000508	0.00264	CcSEcCtD
Acebutolol—Decreased appetite—Fluorouracil—colon cancer	0.000504	0.00262	CcSEcCtD
Acebutolol—Alopecia—Capecitabine—colon cancer	0.000504	0.00262	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000501	0.0026	CcSEcCtD
Acebutolol—Feeling abnormal—Irinotecan—colon cancer	0.000499	0.00259	CcSEcCtD
Acebutolol—Dysuria—Methotrexate—colon cancer	0.000496	0.00257	CcSEcCtD
Acebutolol—Pain—Fluorouracil—colon cancer	0.000496	0.00257	CcSEcCtD
Acebutolol—Gastrointestinal pain—Irinotecan—colon cancer	0.000495	0.00257	CcSEcCtD
Acebutolol—Body temperature increased—Vincristine—colon cancer	0.000492	0.00255	CcSEcCtD
Acebutolol—Abdominal pain—Vincristine—colon cancer	0.000492	0.00255	CcSEcCtD
Acebutolol—Flatulence—Capecitabine—colon cancer	0.000489	0.00254	CcSEcCtD
Acebutolol—Erectile dysfunction—Methotrexate—colon cancer	0.000489	0.00254	CcSEcCtD
Acebutolol—Back pain—Capecitabine—colon cancer	0.00048	0.00249	CcSEcCtD
Acebutolol—Abdominal pain—Irinotecan—colon cancer	0.000479	0.00248	CcSEcCtD
Acebutolol—Body temperature increased—Irinotecan—colon cancer	0.000479	0.00248	CcSEcCtD
Acebutolol—Feeling abnormal—Fluorouracil—colon cancer	0.000478	0.00248	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—colon cancer	0.000476	0.00247	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—colon cancer	0.000473	0.00245	CcSEcCtD
Acebutolol—Depression—Methotrexate—colon cancer	0.000472	0.00245	CcSEcCtD
Acebutolol—Vision blurred—Capecitabine—colon cancer	0.000468	0.00243	CcSEcCtD
Acebutolol—Ill-defined disorder—Capecitabine—colon cancer	0.000461	0.00239	CcSEcCtD
Acebutolol—Urticaria—Fluorouracil—colon cancer	0.000461	0.00239	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—colon cancer	0.00046	0.00239	CcSEcCtD
Acebutolol—Body temperature increased—Fluorouracil—colon cancer	0.000458	0.00238	CcSEcCtD
Acebutolol—Sweating—Methotrexate—colon cancer	0.000454	0.00235	CcSEcCtD
Acebutolol—Malaise—Capecitabine—colon cancer	0.000448	0.00232	CcSEcCtD
Acebutolol—Vertigo—Capecitabine—colon cancer	0.000446	0.00231	CcSEcCtD
Acebutolol—Asthenia—Vincristine—colon cancer	0.000446	0.00231	CcSEcCtD
Acebutolol—Syncope—Capecitabine—colon cancer	0.000445	0.00231	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—colon cancer	0.000441	0.00229	CcSEcCtD
Acebutolol—Palpitations—Capecitabine—colon cancer	0.000439	0.00228	CcSEcCtD
Acebutolol—Loss of consciousness—Capecitabine—colon cancer	0.000436	0.00226	CcSEcCtD
Acebutolol—Asthenia—Irinotecan—colon cancer	0.000434	0.00225	CcSEcCtD
Acebutolol—Cough—Capecitabine—colon cancer	0.000433	0.00225	CcSEcCtD
Acebutolol—Diarrhoea—Vincristine—colon cancer	0.000425	0.00221	CcSEcCtD
Acebutolol—Arthralgia—Capecitabine—colon cancer	0.000423	0.00219	CcSEcCtD
Acebutolol—Chest pain—Capecitabine—colon cancer	0.000423	0.00219	CcSEcCtD
Acebutolol—Myalgia—Capecitabine—colon cancer	0.000423	0.00219	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—colon cancer	0.000421	0.00219	CcSEcCtD
Acebutolol—Anxiety—Capecitabine—colon cancer	0.000421	0.00219	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00042	0.00218	CcSEcCtD
Acebutolol—Discomfort—Capecitabine—colon cancer	0.000418	0.00217	CcSEcCtD
Acebutolol—Diarrhoea—Irinotecan—colon cancer	0.000414	0.00215	CcSEcCtD
Acebutolol—Dizziness—Vincristine—colon cancer	0.000411	0.00213	CcSEcCtD
Acebutolol—Pruritus—Fluorouracil—colon cancer	0.00041	0.00213	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—colon cancer	0.000409	0.00212	CcSEcCtD
Acebutolol—Confusional state—Capecitabine—colon cancer	0.000409	0.00212	CcSEcCtD
Acebutolol—Oedema—Capecitabine—colon cancer	0.000405	0.0021	CcSEcCtD
Acebutolol—Dizziness—Irinotecan—colon cancer	0.0004	0.00208	CcSEcCtD
Acebutolol—Shock—Capecitabine—colon cancer	0.000399	0.00207	CcSEcCtD
Acebutolol—Nervous system disorder—Capecitabine—colon cancer	0.000397	0.00206	CcSEcCtD
Acebutolol—Diarrhoea—Fluorouracil—colon cancer	0.000397	0.00206	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—colon cancer	0.000396	0.00205	CcSEcCtD
Acebutolol—Vomiting—Vincristine—colon cancer	0.000395	0.00205	CcSEcCtD
Acebutolol—Skin disorder—Capecitabine—colon cancer	0.000394	0.00204	CcSEcCtD
Acebutolol—Rash—Vincristine—colon cancer	0.000392	0.00203	CcSEcCtD
Acebutolol—Hyperhidrosis—Capecitabine—colon cancer	0.000392	0.00203	CcSEcCtD
Acebutolol—Dermatitis—Vincristine—colon cancer	0.000392	0.00203	CcSEcCtD
Acebutolol—Headache—Vincristine—colon cancer	0.00039	0.00202	CcSEcCtD
Acebutolol—Anorexia—Capecitabine—colon cancer	0.000386	0.002	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—colon cancer	0.000385	0.002	CcSEcCtD
Acebutolol—Vomiting—Irinotecan—colon cancer	0.000385	0.002	CcSEcCtD
Acebutolol—Dizziness—Fluorouracil—colon cancer	0.000384	0.00199	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—colon cancer	0.000383	0.00199	CcSEcCtD
Acebutolol—Rash—Irinotecan—colon cancer	0.000382	0.00198	CcSEcCtD
Acebutolol—Dermatitis—Irinotecan—colon cancer	0.000381	0.00198	CcSEcCtD
Acebutolol—Chills—Methotrexate—colon cancer	0.000381	0.00198	CcSEcCtD
Acebutolol—Headache—Irinotecan—colon cancer	0.000379	0.00197	CcSEcCtD
Acebutolol—Hypotension—Capecitabine—colon cancer	0.000379	0.00197	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—colon cancer	0.000375	0.00195	CcSEcCtD
Acebutolol—Nausea—Vincristine—colon cancer	0.000369	0.00192	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000369	0.00192	CcSEcCtD
Acebutolol—Vomiting—Fluorouracil—colon cancer	0.000369	0.00191	CcSEcCtD
Acebutolol—Insomnia—Capecitabine—colon cancer	0.000367	0.0019	CcSEcCtD
Acebutolol—Rash—Fluorouracil—colon cancer	0.000366	0.0019	CcSEcCtD
Acebutolol—Dermatitis—Fluorouracil—colon cancer	0.000365	0.0019	CcSEcCtD
Acebutolol—Paraesthesia—Capecitabine—colon cancer	0.000364	0.00189	CcSEcCtD
Acebutolol—Headache—Fluorouracil—colon cancer	0.000363	0.00189	CcSEcCtD
Acebutolol—Dyspnoea—Capecitabine—colon cancer	0.000361	0.00187	CcSEcCtD
Acebutolol—Nausea—Irinotecan—colon cancer	0.00036	0.00187	CcSEcCtD
Acebutolol—Back pain—Methotrexate—colon cancer	0.000358	0.00186	CcSEcCtD
Acebutolol—Dyspepsia—Capecitabine—colon cancer	0.000357	0.00185	CcSEcCtD
Acebutolol—Decreased appetite—Capecitabine—colon cancer	0.000352	0.00183	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Capecitabine—colon cancer	0.00035	0.00182	CcSEcCtD
Acebutolol—Fatigue—Capecitabine—colon cancer	0.000349	0.00181	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—colon cancer	0.000348	0.00181	CcSEcCtD
Acebutolol—Constipation—Capecitabine—colon cancer	0.000347	0.0018	CcSEcCtD
Acebutolol—Pain—Capecitabine—colon cancer	0.000347	0.0018	CcSEcCtD
Acebutolol—Nausea—Fluorouracil—colon cancer	0.000345	0.00179	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—colon cancer	0.000343	0.00178	CcSEcCtD
Acebutolol—Feeling abnormal—Capecitabine—colon cancer	0.000334	0.00173	CcSEcCtD
Acebutolol—Malaise—Methotrexate—colon cancer	0.000333	0.00173	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—colon cancer	0.000332	0.00172	CcSEcCtD
Acebutolol—Gastrointestinal pain—Capecitabine—colon cancer	0.000331	0.00172	CcSEcCtD
Acebutolol—Cough—Methotrexate—colon cancer	0.000323	0.00167	CcSEcCtD
Acebutolol—Urticaria—Capecitabine—colon cancer	0.000322	0.00167	CcSEcCtD
Acebutolol—Body temperature increased—Capecitabine—colon cancer	0.00032	0.00166	CcSEcCtD
Acebutolol—Abdominal pain—Capecitabine—colon cancer	0.00032	0.00166	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—colon cancer	0.000315	0.00163	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—colon cancer	0.000315	0.00163	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—colon cancer	0.000315	0.00163	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000313	0.00162	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—colon cancer	0.000311	0.00161	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—colon cancer	0.000304	0.00158	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—colon cancer	0.000296	0.00154	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—colon cancer	0.000293	0.00152	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—colon cancer	0.000292	0.00151	CcSEcCtD
Acebutolol—Asthenia—Capecitabine—colon cancer	0.000291	0.00151	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—colon cancer	0.000288	0.00149	CcSEcCtD
Acebutolol—Pruritus—Capecitabine—colon cancer	0.000287	0.00149	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—colon cancer	0.000282	0.00146	CcSEcCtD
Acebutolol—Diarrhoea—Capecitabine—colon cancer	0.000277	0.00144	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000275	0.00143	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—colon cancer	0.000273	0.00142	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—colon cancer	0.000271	0.00141	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—colon cancer	0.000269	0.0014	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—colon cancer	0.000268	0.00139	CcSEcCtD
Acebutolol—Dizziness—Capecitabine—colon cancer	0.000268	0.00139	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—colon cancer	0.000266	0.00138	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—colon cancer	0.000262	0.00136	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00026	0.00135	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—colon cancer	0.00026	0.00135	CcSEcCtD
Acebutolol—Propranolol—ABCB1—colon cancer	0.000258	0.181	CrCbGaD
Acebutolol—Pain—Methotrexate—colon cancer	0.000258	0.00134	CcSEcCtD
Acebutolol—Vomiting—Capecitabine—colon cancer	0.000258	0.00134	CcSEcCtD
Acebutolol—Rash—Capecitabine—colon cancer	0.000256	0.00133	CcSEcCtD
Acebutolol—Dermatitis—Capecitabine—colon cancer	0.000255	0.00132	CcSEcCtD
Acebutolol—Headache—Capecitabine—colon cancer	0.000254	0.00132	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—colon cancer	0.000249	0.00129	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—colon cancer	0.000247	0.00128	CcSEcCtD
Acebutolol—Nausea—Capecitabine—colon cancer	0.000241	0.00125	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—colon cancer	0.00024	0.00124	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—colon cancer	0.000239	0.00124	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—colon cancer	0.000239	0.00124	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—colon cancer	0.000216	0.00112	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—colon cancer	0.000213	0.00111	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—colon cancer	0.000206	0.00107	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—colon cancer	0.0002	0.00104	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—colon cancer	0.000192	0.000995	CcSEcCtD
Acebutolol—Rash—Methotrexate—colon cancer	0.00019	0.000987	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—colon cancer	0.00019	0.000986	CcSEcCtD
Acebutolol—Headache—Methotrexate—colon cancer	0.000189	0.000981	CcSEcCtD
Acebutolol—Nausea—Methotrexate—colon cancer	0.000179	0.00093	CcSEcCtD
